Press-release for stocks for eli lilly and company

Prices are updated after-hours

entities : Eli lilly and company

save search

FDA Roundup: December 5, 2023
Published: 2023-12-05 (Crawled : 14:30) - fda.gov
LLY | News | $588.27 -0.17% -0.1% 2.1M

Health Technology

| 0.99% | O: 0.99% H: 0.0% C: 0.0%
fda

Metastatic Castration-Sensitive Prostate Cancer Market to Skyrocket at Astounding 22% CAGR During the Study Period (2019-2032), assesses DelveInsight
Published: 2023-12-06 (Crawled : 22:00) - prnewswire.com
LLY | News | $588.27 -0.17% -0.1% 2.1M

Health Technology

| 0.0% | O: -0.35% H: 0.0% C: 0.0%
cancer study market

The Top 12 Biopharma Companies Hiring Now
Published: 2023-12-06 (Crawled : 22:00) - biospace.com/
LLY | News | $588.27 -0.17% -0.1% 2.1M

Health Technology

| 0.99% | O: 0.99% H: 0.0% C: 0.0%
companies biopharma

Parkinson's Disease Therapeutics Market revenue to hit USD 12.32 Billion by 2033, Says We Market Research
Published: 2023-12-06 (Crawled : 15:30) - prnewswire.com
NVS | News | $95.93 -1.15% 0.0% 1.2M

Health Technology

| 0.17% | O: 0.17% H: 0.0% C: 0.0%
GSK | News | $36.0 -0.47% 0.06% 2.2M

Health Technology

| 0.03% | O: 0.03% H: 0.0% C: 0.0%
LLY | News | $588.27 -0.17% -0.1% 2.1M

Health Technology

| 0.99% | O: 0.99% H: 0.0% C: 0.0%
ABBV | News | $147.97 1.09% 0.05% 7.2M

Health Technology

| 0.26% | O: 0.26% H: 0.0% C: 0.0%
DNLI | News | $18.72 -2.19% -2.24% 1.1M

Health Technology

| -0.22% | O: -0.22% H: 0.0% C: 0.0%
BIIB | News | $239.14 2.25% 2.2% 1.2M

Health Technology

| 0.46% | O: 0.46% H: 0.0% C: 0.0%
disease parkinson's revenue research therapeutics market

Abcuro Appoints Mark Pruzanski, M.D., as Chairman of its Board of Directors
Published: 2023-12-06 (Crawled : 15:30) - biospace.com/
LLY | News | $588.27 -0.17% -0.1% 2.1M

Health Technology

| 0.99% | O: 0.99% H: 0.0% C: 0.0%

Innovent Announces the Phase 3 ORIENT-16 Study Results Published in JAMA Evaluating Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma
Published: 2023-12-06 (Crawled : 01:00) - prnewswire.com
LLY | News | $588.27 -0.17% -0.1% 2.1M

Health Technology

| 0.99% | O: 0.99% H: 0.0% C: 0.0%
SNY | News | $46.06 0.17% 0.17% 1.9M

Health Technology

| -0.6% | O: -0.6% H: 0.0% C: 0.0%
INCY | News | $55.17 -0.45% -0.45% 1.3M

Health Technology

| -0.55% | O: -0.55% H: 0.0% C: 0.0%
rient-16 treatment results study

FDA Roundup: December 05, 2023
Published: 2023-12-05 (Crawled : 23:00) - prnewswire.com
LLY | News | $588.27 -0.17% -0.1% 2.1M

Health Technology

| 0.99% | O: 0.99% H: 0.0% C: 0.0%
fda

Vanda Pharmaceuticals Announces that U.S. Food and Drug Administration Accepts New Drug Application for Tradipitant for the Treatment of Gastroparesis
Published: 2023-12-04 (Crawled : 23:00) - prnewswire.com
LLY | News | $588.27 -0.17% -0.1% 2.1M

Health Technology

| 1.08% | O: 0.08% H: 0.0% C: 0.0%
VNDA | $3.96 -1.98% -2.02% 1.5M

Health Technology

| 0.89% | O: 0.13% H: 1.53% C: 0.76%
drug food treatment pharmaceuticals application

Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 15, 2023
Published: 2023-12-04 (Crawled : 14:30) - biospace.com/
LLY | News | $588.27 -0.17% -0.1% 2.1M

Health Technology

| -0.9% | O: -1.96% H: 0.0% C: 0.0%
biopharma acquire

Jaypirca® (pirtobrutinib) Now Approved by U.S. FDA for the Treatment of Adult Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Received at Least Two Lines of Therapy, Including a BTK Inhibitor and a BCL-2 Inhibitor
Published: 2023-12-01 (Crawled : 23:00) - prnewswire.com
LLY | News | $588.27 -0.17% -0.1% 2.1M

Health Technology

| Email alert Add to watchlist
jaypirca fda approved treatment leukemia

Verve Therapeutics Announces Closing of Public Offering of Common Stock, Full Exercise by Underwriters of Option to Purchase Additional Shares and Closing of Concurrent Private Placement
Published: 2023-12-01 (Crawled : 21:00) - globenewswire.com
VERV | $12.89 3.2% 3.1% 1.4M

Professional, Scientific, and T...

| Email alert Add to watchlist
LLY | News | $588.27 -0.17% -0.1% 2.1M

Health Technology

| Email alert Add to watchlist
offering therapeutics

AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO
Published: 2023-12-01 (Crawled : 17:00) - globenewswire.com
LLY | News | $588.27 -0.17% -0.1% 2.1M

Health Technology

| -0.4% | O: 0.5% H: 0.0% C: 0.0%
ACIU | $3.55 -0.56% -0.56% 85K

Health Technology

| 8.86% | O: 2.64% H: 0.0% C: 0.0%

Acute Myocardial Infarction Treatment Market to Show Immense Growth at a CAGR of 7.7% During the Study Period (2019-2032), Predicts DelveInsight
Published: 2023-11-30 (Crawled : 22:00) - prnewswire.com
LLY | News | $588.27 -0.17% -0.1% 2.1M

Health Technology

| -0.4% | O: 0.5% H: 0.0% C: 0.0%
treatment show growth study market

Zealand Pharma appoints Enrique Conterno and Elaine Sullivan as board observers
Published: 2023-11-30 (Crawled : 08:00) - biospace.com/
LLY | News | $588.27 -0.17% -0.1% 2.1M

Health Technology